Officials with the University of Arkansas for Medical Sciences in Little Rock say one of its cancer centers has received about $20 million in state funding and philanthropic contributions.
In an announcement Tuesday, UAMS officials say the funding will help pay for new laboratory construction and research programs by the Myeloma Institute for Research and Therapy. They say the myeloma institute received about $5 million from the state's General Improvement Funds, which was matched 3-to-1 by philanthropic contributions.
The first matching gift was $5 million and was made by the Goldman Sachs Philanthropy Fund.
The center researches and offers clinical care of multiple myeloma - a rare form of bone marrow cancer. More than 11,000 patients nationwide and from around the world have sought treatment at the myeloma institute.
The school also said Tuesday that a London doctor has been tapped to serve as the new director for the center.
UAMS officials announced Dr. Gareth Morgan would succeed Dr. Bart Barlogie. Barlogie was the founder and director for the center that was established nearly 25 years ago to research and offer clinical care of multiple myeloma.